S
Sungching Glenn
Publications - 5
Citations - 159
Sungching Glenn is an academic researcher. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 1, co-authored 1 publications receiving 143 citations.
Papers
More filters
Journal ArticleDOI
Invasive fungal infections in pediatric oncology patients: 11-year experience at a single institution.
TL;DR: The incidence of fungal infections in pediatric hematology and oncology patients with various malignancies from 1991 to 2001 increased over time, possibly as a result of advances in antibacterial and chemotherapeutic regimens.
Journal ArticleDOI
A safety study evaluating non-COVID-19 mortality risk following COVID-19 vaccination
Stanley Xu,Runxin Huang,Lina S. Sy,Vennis Hong,Sungching Glenn,Denison S Ryan,Kerresa Morrissette,Gabriela Vazquez-Benitez,Jason M. Glanz,Nicola P. Klein,Bruce Fireman,David L. McClure,Elizabeth Liles,Eric Weintraub,Hung Fu Tseng,Lei Qian +15 more
TL;DR: In this paper , the authors conducted a large cohort study to evaluate the risk of non-COVID-19 vaccination while adjusting for confounders including individual-level demographics, clinical risk factors, health care utilization, and community-level socioeconomic risk factors.
Journal ArticleDOI
Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the Vaccine Safety Datalink
Tat'Yana A. Kenigsberg,Anne M. Hause,Michael M. McNeil,Jennifer C. Nelson,Jo Ann Shoup,Kristin Goddard,Yi-ting Lou,Kayla E. Hanson,Sungching Glenn,Eric Weintraub +9 more
TL;DR: The Vaccine Safety Datalink (VSD) developed an internal dashboard to facilitate visualization and rapid reviews of large weekly automated vaccine safety surveillance data as mentioned in this paper , which may have application across various other public health settings.
Journal ArticleDOI
Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic
Stanley Xu,Vennis Hong,Lina S. Sy,Sungching Glenn,Denison S Ryan,Kerresa Morrissette,Jennifer C. Nelson,Simon J. Hambidge,Bradley Crane,Ousseny Zerbo,Malini B. DeSilva,Jason M. Glanz,James G. Donahue,Elizabeth Liles,Jonathan Duffy,Lei Qian +15 more
TL;DR: Rates of some clinical outcomes during the COVID-19 pandemic changed and should not be used as historical background rates in vaccine safety studies, after adjusting for changes across similar periods in 2017–2019.
Journal ArticleDOI
Reactions following Pfizer-BioNTech COVID-19 mRNA vaccination and related healthcare encounters among 7,077 children aged 5-11 years within an integrated healthcare system
Deborah Malden,Julianne Gee,Sungching Glenn,Zhuoxin Li,Cheryl Mercado,Oluwaseye Ayoola Ogun,Sunhea S Kim,Bruno Lewin,Bradley Ackerson,Amelia Jazwa,Eric Weintraub,Michael M. McNeil,Sara Y. Tartof +12 more
TL;DR: The authors conducted an observational study using data from a digital survey and EHR of children aged 5-11 years vaccinated with Pfizer-BioNTech COVID-19 mRNA vaccine across Kaiser Permanente Southern California during November 4-February 28, 2022.